Beleodaq 500 mg

Home - - Beleodaq 500 mg

Beleodaq 500 mg

International Name : Beleodaq 500 mg

Contains : Belinostat

Manufacturer : Spectrum Pharmaceuticals, Inc.

Form : Bottle

Packing : 1 vial of 30 ml - Vials

Strength : 500 mg

Click Here To Get A Quote

Beleodaq 500 mg

Belinostat is a drug utilized for the treatment of backslid or unmanageable fringe T-cell lymphoma (PTCL).


Belinostat is a histone deacetylase (HDAC) inhibitor demonstrated for the treatment of patients with backslid or recalcitrant fringe T-cell lymphoma (PTCL), which indicates special cytotoxicity towards tumour cells contrasted with ordinary cells1.

A fringe T-cell lymphoma is a gathering of T-cell lymphomas, platelet tumours that influence T-cells, that grow far from the thymus.

Side Effects:

  • Liver problems
  • Serious infections
  • Low blood cell counts
  • Nausea, vomiting, and diarrhoea

Enquiry about Beleodaq 500 mg

    × How can I help you?